Perrigo Company PLC
PRGO15.065USD
+0.125+0.84%
Close 01/13, 16:00（ET）Quotes delayed by 15 min
2.07BMarket Cap
LossP/E TTM
More Details of Perrigo Company PLC Company
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Perrigo Company PLC Info
Ticker SymbolPRGO
Company namePerrigo Company PLC
IPO dateDec 17, 1991
CEOLockwood-Taylor (Patrick)
Number of employees8379
Security typeOrdinary Share
Fiscal year-endDec 17
AddressThe Sharp Building
CityDUBLIN
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryIreland
Postal codeD02 TY74
Phone3532696738451
Websitehttps://www.perrigo.com/
Ticker SymbolPRGO
IPO dateDec 17, 1991
CEOLockwood-Taylor (Patrick)
Company Executives of Perrigo Company PLC
Name
Name/Position
Position
Shareholding
Change
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+4460.00%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+8650.00%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+3000.00%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+1488.00%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+5150.00%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+5150.00%
Ms. Adriana (Andi) Karaboutis
Ms. Adriana (Andi) Karaboutis
Independent Director
Independent Director
27.63K
+5150.00%
Mr. Orlando D. Ashford
Mr. Orlando D. Ashford
Independent Chairman of the Board
Independent Chairman of the Board
22.17K
+6437.00%
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Independent Director
Independent Director
10.56K
+5150.00%
Ms. Julia M. Brown
Ms. Julia M. Brown
Independent Director
Independent Director
8.03K
+5150.00%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+4460.00%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+8650.00%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+3000.00%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+1488.00%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+5150.00%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+5150.00%
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Upper respiratory
182.00M
17.44%
Pain and sleep-aids
169.20M
16.22%
Skincare and personal hygiene
150.60M
14.43%
Healthy lifestyle
133.80M
12.82%
Digestive health
116.10M
11.13%
Other
291.60M
27.95%
By RegionUSD
Name
Revenue
Proportion
United States
635.30M
60.89%
Europe
384.00M
36.81%
All other countries
24.00M
2.30%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Upper respiratory
182.00M
17.44%
Pain and sleep-aids
169.20M
16.22%
Skincare and personal hygiene
150.60M
14.43%
Healthy lifestyle
133.80M
12.82%
Digestive health
116.10M
11.13%
Other
291.60M
27.95%
Shareholding Stats
Updated: Thu, Jan 8
Updated: Thu, Jan 8
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
T. Rowe Price Associates, Inc.
12.20%
The Vanguard Group, Inc.
10.04%
BlackRock Institutional Trust Company, N.A.
8.70%
Dimensional Fund Advisors, L.P.
5.59%
State Street Investment Management (US)
5.02%
Other
58.46%
Shareholders
Shareholders
Proportion
T. Rowe Price Associates, Inc.
12.20%
The Vanguard Group, Inc.
10.04%
BlackRock Institutional Trust Company, N.A.
8.70%
Dimensional Fund Advisors, L.P.
5.59%
State Street Investment Management (US)
5.02%
Other
58.46%
Shareholder Types
Shareholders
Proportion
Investment Advisor
64.13%
Investment Advisor/Hedge Fund
37.62%
Hedge Fund
5.32%
Research Firm
2.06%
Pension Fund
1.58%
Sovereign Wealth Fund
1.12%
Bank and Trust
0.47%
Individual Investor
0.44%
Insurance Company
0.06%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
757
155.20M
112.77%
-15.97M
2025Q3
771
148.06M
107.58%
-20.94M
2025Q2
791
145.85M
106.01%
-21.49M
2025Q1
812
142.34M
103.61%
-25.15M
2024Q4
806
140.28M
102.80%
-22.73M
2024Q3
798
138.34M
101.41%
-20.68M
2024Q2
800
136.29M
99.93%
-16.34M
2024Q1
799
135.97M
99.77%
-20.56M
2023Q4
809
135.31M
99.86%
-23.17M
2023Q3
797
133.80M
98.82%
-17.47M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
T. Rowe Price Associates, Inc.
16.79M
12.2%
+2.36M
+16.34%
Sep 30, 2025
The Vanguard Group, Inc.
13.82M
10.04%
-144.87K
-1.04%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
11.97M
8.7%
+209.84K
+1.78%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
7.70M
5.59%
+181.83K
+2.42%
Sep 30, 2025
State Street Investment Management (US)
6.90M
5.02%
-437.33K
-5.96%
Sep 30, 2025
Neuberger Berman, LLC
5.73M
4.16%
+2.02M
+54.36%
Sep 30, 2025
Cooke & Bieler, L.P.
3.68M
2.67%
+381.29K
+11.56%
Sep 30, 2025
Sound Shore Management, Inc.
3.65M
2.65%
+363.33K
+11.05%
Sep 30, 2025
Thompson, Siegel & Walmsley LLC
3.63M
2.64%
+1.30M
+56.12%
Sep 30, 2025
DePrince, Race & Zollo, Inc.
3.54M
2.57%
-1.03M
-22.50%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Sound Equity Dividend Income ETF
3.3%
State Street SPDR S&P Pharmaceuticals ETF
2.44%
Invesco Pharmaceuticals ETF
2.34%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
1.54%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.35%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
1.32%
First Trust Health Care Alphadex Fund
1.22%
Invesco S&P MidCap 400 Pure Value ETF
1.19%
Invesco High Yield Equity Dividend Achievers ETF
1.11%
iShares U.S. Pharmaceuticals ETF
1.05%
View more
Sound Equity Dividend Income ETF
Proportion3.3%
State Street SPDR S&P Pharmaceuticals ETF
Proportion2.44%
Invesco Pharmaceuticals ETF
Proportion2.34%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
Proportion1.54%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion1.35%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
Proportion1.32%
First Trust Health Care Alphadex Fund
Proportion1.22%
Invesco S&P MidCap 400 Pure Value ETF
Proportion1.19%
Invesco High Yield Equity Dividend Achievers ETF
Proportion1.11%
iShares U.S. Pharmaceuticals ETF
Proportion1.05%
Dividend
A total of
574.20M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Oct 29, 2025
PRGO.NB Final Cash Dividend of gross USD 0.29 paid on Dec 16, 2025 going ex on Nov 28, 2025
Nov 28, 2025
Dec 16, 2025
Nov 28, 2025
Jul 30, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Sep 16, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 16, 2025
Aug 29, 2025
Apr 30, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Jun 17, 2025 going ex on May 30, 2025
May 30, 2025
Jun 17, 2025
May 30, 2025
Feb 19, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Mar 25, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 25, 2025
Mar 07, 2025
Nov 01, 2024
PRGO.NB Final Cash Dividend of gross USD 0.276 paid on Dec 17, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 17, 2024
Nov 29, 2024
Aug 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Sep 17, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 17, 2024
Aug 30, 2024
May 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Jun 18, 2024 going ex on May 31, 2024
May 31, 2024
Jun 18, 2024
May 31, 2024
Feb 26, 2024
PRGO.NB Interim Cash Dividend of gross USD 1.1 paid on Mar 26, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 26, 2024
Mar 07, 2024
Nov 03, 2023
PRGO.NB Final Cash Dividend of gross USD 0.273 paid on Dec 19, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 19, 2023
Nov 30, 2023
Aug 02, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Sep 19, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 19, 2023
Aug 31, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Perrigo Company PLC?
The top five shareholders of Perrigo Company PLC are:
T. Rowe Price Associates, Inc. holds 16.79M shares, accounting for 12.20% of the total shares.
The Vanguard Group, Inc. holds 13.82M shares, accounting for 10.04% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 11.97M shares, accounting for 8.70% of the total shares.
Dimensional Fund Advisors, L.P. holds 7.70M shares, accounting for 5.59% of the total shares.
State Street Investment Management (US) holds 6.90M shares, accounting for 5.02% of the total shares.
T. Rowe Price Associates, Inc. holds 16.79M shares, accounting for 12.20% of the total shares.
The Vanguard Group, Inc. holds 13.82M shares, accounting for 10.04% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 11.97M shares, accounting for 8.70% of the total shares.
Dimensional Fund Advisors, L.P. holds 7.70M shares, accounting for 5.59% of the total shares.
State Street Investment Management (US) holds 6.90M shares, accounting for 5.02% of the total shares.
What are the top three shareholder types of Perrigo Company PLC?
The top three shareholder types of Perrigo Company PLC are:
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of Perrigo Company PLC (PRGO)?
As of 2025Q4, 757 institutions hold shares of Perrigo Company PLC, with a combined market value of approximately 155.20M, accounting for 112.77% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 5.19%.
What is the biggest source of revenue for Perrigo Company PLC?
In FY2025Q3, the Upper respiratory business generated the highest revenue for Perrigo Company PLC, amounting to 182.00M and accounting for 17.44% of total revenue.
